Fidelta provides a broad range of high quality in vitro assays with rapid turnover, covering target-based or phenotypic drug discovery from hit finding to lead optimization phase.

A number of biochemical and cell based assays in the areas of infection, inflammation, fibrosis and oncology have been set-up and validated in the last 15 years. Assays can be customised and applied to any specific project needs.

For more information on our capabilities please contact us.